Healthy excessive weight in Portuguese women 4years after delivery of a liveborn by Henriques, A et al.
Preventive Medicine 75 (2015) 49–55
Contents lists available at ScienceDirect
Preventive Medicine
j ourna l homepage: www.e lsev ie r .com/ locate /ypmedHealthy excessive weight in Portuguese women 4 years after delivery of
a livebornAna Henriques a,⁎, Ana Cristina Santos a,b, João Tiago Guimarães a,b,c, Henrique Barros a,b, Ana Azevedo a,b
a EPIUnit — Institute of Public Health, University of Porto, Porto, Portugal
b Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal
c Department of Clinical Pathology, Centro Hospitalar São João, Porto, Portugal⁎ Corresponding author at: Institute of Public Health—
das Taipas no 135, 4050-600 Porto, Portugal. Fax: +351 2
E-mail address: alhenriques@med.up.pt (A. Henriques
http://dx.doi.org/10.1016/j.ypmed.2015.03.009
0091-7435/© 2015 Elsevier Inc. All rights reserved.a b s t r a c ta r t i c l e i n f oAvailable online 12 March 2015Keywords:
Motherhood
Excessive weight
Healthy metabolic proﬁle
Objective. To quantify the prevalence of healthy excessiveweight and determinants ofmetabolic proﬁle, con-
sidering women's reproductive life.
Methods.Weevaluated 1847mothers of a birth cohort assembled after delivery and reevaluated 4 years later.
A healthy proﬁle was deﬁned as the absence of hypertension, diabetes, dyslipidemia, C-reactive protein b3 mg/l
and being below the second tertile of HOMA-IR. Adjusted odds ratios (OR) and conﬁdence intervals (95% CI)
were computed using multinomial logistic regression, taking womenwith normal BMI as the reference category
of the outcome.
Results. Four years after delivery, 47% of women had normal BMI, 33% were overweight and 20% obese. In
each BMI class, 61%, 33% and 12% presented a healthy metabolic proﬁle, respectively. Family history of CVD/
cardiometabolic risk factors was associatedwith a higher probability of obesity with a not healthymetabolic pro-
ﬁle (OR= 1.39 95% CI: 0.98–1.98). Women who breastfed the enrolled child for N26 weeks and practiced phys-
ical exercise were less likely to be obese and metabolically unhealthy (OR = 0.39 95% CI: 0.23–0.68; OR = 0.48
95% CI: 0.33–0.70, respectively), with no effect on healthy excessive weight.
Conclusions. These results support the existence of a healthy excessive weight phenotype in women after
motherhood, inﬂuenced by anthropometrics, genetic and lifestyles characteristics.© 2015 Elsevier Inc. All rights reserved.Introduction
Overweight and obesity are increasingly prevalent worldwide and
expected to be one of the major public health problems of the XXI cen-
tury (Finucane et al., 2011). In Portugal, 20% of women in their thirties
are overweight and 8% obese (Carreira et al., 2012) and this increase
in excessive body weight will have an important impact on the global
incidence of several diseases, (Visscher and Seidell, 2001). However, a
subset of obese subjects seems to be protected fromobesity-related car-
diovascular and cardiometabolic abnormalities (Pataky et al., 2011;
Stefan et al., 2008; Karelis, 2008; Manu et al., 2012). The phenotype
called healthy obesity is characterized by a favorable metabolic proﬁle:
high levels of insulin sensitivity, no hypertension, as well as a favorable
inﬂammatory (Phillips and Perry, 2013), lipid, hormonal and immune
proﬁle (Primeau et al., 2011). The importance of recognizing this
phenotype is strengthened by the fact that weight loss may adversely
impact the favorable metabolic proﬁle (Karelis et al., 2008; Shin et al.,
2006).University of Porto (ISPUP), Rua
22 061 821.
).Despite the absence of a uniform deﬁnition for this subtype of obesi-
ty, the literature shows a high prevalence of healthy obese individuals
(Wildman, 2009; Bluher, 2010), ranging from 6% to 37% (Kuk and
Ardern, 2009; Brochu et al., 2001; Phillips et al., 2013). Even when
unique criteria are used, considerable variability in the prevalence of
healthy obesity is found across different European countries (Van
Vliet-Ostaptchouk et al., 2014) and, to the best of our knowledge,
there are no estimates for Portugal.
Abdominal fat seems to be linked to amore adverse cardiometabolic
proﬁle (Thomas et al., 2012; Jensen, 2008). The increase of fat deposi-
tion in abdominal visceral adipose tissue is favored after pregnancy
due to increased abdominal compliance, rendering women more sus-
ceptible to abdominal obesity after childbirth (Gunderson et al., 2008)
and it remains unclear to which extent this abdominal fat is associated
with metabolic complications.
Thus, it is interesting to characterize overweight and obesity pheno-
types in women who had a child, thus supporting or not the need for
preventive action directed at this segment of the population. Speciﬁ-
cally, we intend to (a) quantify the prevalence of healthy excessive
weight in a cohort of Portuguese women 4 years after delivering a
child, (b) assess the dependence of a healthy metabolic proﬁle on the
distribution and BMI evolution from prepregnancy to 4 years later and
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vascular diseases (CVD) or cardiometabolic risk factors, reproductive
history and lifestyles are associated with this metabolically healthy
phenotype.
Materials and methods
Study design and participants
This study is based on the birth cohort Generation XXI described elsewhere
(Alves et al., 2012). Brieﬂy, in 2005–2006, 8495women, who gave birth to 8647
infants, were enrolled into the cohort after the child's birth. Theywere recruited
in thematernity clinics ofﬁve public hospitals covering themetropolitan area of
Porto, Portugal within 72 h after delivery.
Four years after birth, in 2009–2011, a follow-up took place and 84.2% of the
mothers were reevaluated. Of all mothers, 5729 (67.4%) attended a face-to-face
evaluation, comprising questionnaires and physical examination (anthropo-
metrics and blood pressure) and 1428 (16.8%) provided self-reported data by
telephone interview. Women interviewed by telephone were excluded due to
the lack of physical examination data. Among those who attended the face-to-
face interview, half were randomly selected to provide a fasting blood sample.
From the 2733 mothers who provided a fasting blood sample, we excluded
from the current analysis 553 who had subsequent pregnancies after the base-
line evaluation, 175 with a C-reactive protein level above 10 mg/l, which sug-
gests a clinically relevant inﬂammatory condition (Yeh and Willerson, 2003),
28with bodymass index (BMI) b18.5 kg/m2 at follow-up and 130withmissing
data on BMI, waist circumference, diabetes, dyslipidemia, hypertension, C-
reactive protein or insulin resistance, leaving 1847 women for the current
analysis.
Exposure variables
During reevaluation, socioeconomic characteristics, personal and family his-
tory of disease, obstetric history and lifestyles of the womenwere self-reported.
Women's agewas collected as a continuous variable. Educationwas collected as
a continuous variable considering the complete years of schooling and later cat-
egorized.Working conditionwas deﬁned as employed, unemployed, housewife
and others (student or retired). Marital status at follow-up was categorized as
married/living together and others (separated, divorced,widowor single). Fam-
ily history of CVD or cardiometabolic risk factors was considered when women
reported having at least one parent or sibling with diabetes, hypertension, dys-
lipidemia, stroke or myocardial infarction. The number of pregnancies was re-
corded including the enrolled infant and the mode of delivery was classiﬁed
as vaginal or caesarean section. Duration of breastfeeding was recorded as the
period of time that the child received maternal milk exclusively or together
with complementary foods, in weeks. Information about hormonal contracep-
tives included ever use of hormonal contraceptives (contraceptive pill, patch
or ring and subdermal implant) and duration of use, andwomenwere then clas-
siﬁed as never, former and current users.
Current smokers included both daily and occasional smokers, and ex-
smokers those that did not smoke for at least 6 months. Physical exercise was
considered as the practice of any type of exercise regardless of the intensity or
duration.
Waist circumferencewasmeasuredmidway between the lowest rib and the
superior border of the iliac crest and a waist circumference N88 cm deﬁned
abdominal obesity (Grundy et al., 2005). To study the BMI evolution from
prepregnancy to 4 years later a variable was deﬁned as the difference between
prepregnancy BMI and BMI 4 years later and comprised three categories: those
who had an increase, a decrease and those who maintained the same BMI dur-
ing this period.
Outcome variables
Weight was measured and recorded to the nearest 0.1 kg in light clothing,
and height was measured without shoes to the nearest 0.1 cm and mothers'
BMI 4 years after delivery was categorized according to the World Health
Organization (1998). The same procedure was used for the prepregnancy
BMI but using self-reported weight. Blood pressure was measured by non-
physician trained interviewers. Twomeasurements of blood pressure separated
by 5 min were taken with an automatic upper arm blood pressure monitor
(OMRON M6 comfort (HEM-7000-E)) after 10-minute rest, on the dominant
upper arm resting at the heart level. The mean was calculated and when thedifference was larger than 5 mm Hg for systolic or diastolic blood pressure a
thirdmeasurement was taken and themean of the 2 closest values was consid-
ered. Hypertension was deﬁned as systolic and/or diastolic blood pressure ≥
140/90 mm Hg and/or self-reported antihypertensive drug therapy prescribed
for Hypertension Guidelines (2007).
Blood was sampled after an overnight fast of at least 10 h and all the pa-
rameters were measured using automatic standard enzymatic methods. Dys-
lipidemia was considered when one of these conditions was veriﬁed: total
cholesterol ≥ 240 mg/dl, high-density lipoprotein (HDL) ≤ 40 mg/dl, low-
density lipoprotein (LDL) ≥ 160 mg/dl, triglycerides ≥ 200 mg/dl or self-
reported antidyslipidemic drug therapy (ATP III Report, 2002). Diabetes
mellitus was deﬁned as fasting plasma glucose concentration ≥ 126 mg/dl or
self-reported antidiabetic drug therapy prescribed speciﬁcally for diabetes
(IDF, 2014). Regarding C-reactive protein, more than N3 mg/l was deﬁned as
the threshold beyond which women were considered to have a higher risk for
cardiovascular events (Cox et al., 2012). Homeostasismodel assessment of insu-
lin resistance (HOMA-IR) was derived from fasting glucose and insulin concen-
trations as [(fasting plasma glucose (mmol/l) ∗ fasting serum insulin (μU/ml)) /
22.5] (Matthews et al., 1985). Low HOMA-IR values indicate high insulin sensi-
tivity, whereas high HOMA-IR values indicate low insulin sensitivity (insulin re-
sistance). The entire sample was divided into insulin-resistant (upper third of
HOMA) and insulin-sensitive (lower and middle thirds of HOMA). The sample-
derived HOMA cut-off value for insulin resistance was 1.803.
A metabolically healthy proﬁle was deﬁned as the absence of hypertension,
diabetes, dyslipidemia, a level of C-reactive protein until 3mg/l and being below
the second tertile of HOMA.
To deﬁne the main outcome, we considered several obesity proﬁles con-
sidering BMI (normal/overweight/obese) and metabolic proﬁle (healthy/not
healthy) resulting in ﬁve groups: women with normal BMI, overweight
women metabolically healthy, overweight women metabolically not healthy,
obese women metabolically healthy and obese women metabolically not
healthy.
Statistical analysis
Statistical analysis was performed using the statistical software Stata 11.0
(College Station, TX, 2009). Sample characteristics are presented as counts and
proportions for categorical variables and mean and standard deviation (SD)
for normally distributed continuous variables. Proportions were compared
using the chi-square test and continuous variables with independent sample
Student's t test, Kruskal–Wallis test or ANOVA. The association of putative deter-
minants with the outcome was assessed using multinomial logistic regression.
Crude and adjusted odds ratios (OR) and 95% conﬁdence intervals (95% CI)
were computed, taking women with normal BMI as the reference category of
the outcome. From a list of a priori potential determinants, a ﬁnal model was
conducted comprising only variables associated with the outcome.
Ethics
All the phases of the study complied with the Ethical Principles for Medical
Research Involving Human Subjects expressed in the Declaration of Helsinki.
The study was approved by the University of Porto Medical School/Centro
Hospitalar de São João ethics committee and a signed informed consent was ob-
tained from all participants.
Results
Four years after delivery, 46.9% of women had a normal BMI, 33.2%
were overweight and 19.9% obese. In this sample, obese women were
the oldest, with a mean (SD) age of 35.3 (5.3) years. Compared to
women with normal BMI, obese women more often had lower levels
of education, were unemployed and had three or more pregnancies.
Regarding the index pregnancy, the prevalence of caesarean section
was higher among obese women than among normal or overweight
women. At the time of the follow-up evaluation, more than half of the
womenwith normal BMI and overweight were using hormonal contra-
ceptives. Obesewomen less often practiced any type of regular physical
exercise. Almost 90% of the obese women had a waist circumference
above 88 cm contrasting with only 2% of women with normal BMI. Al-
most all women with normal BMI 4 years after delivery were already
51A. Henriques et al. / Preventive Medicine 75 (2015) 49–55in this BMI category before pregnancy,while in both categories of exces-
sive weight more than half of the women had recently gained consider-
able weight enough to move across BMI categories (Table 1).
There was a gradient between all metabolic parameters considered
and women's BMI 4 years after delivery, with obese women presenting
the least favorable proﬁle. Among obesewomen 4 years after delivery, 1
out of 10 had ametabolic healthy proﬁle, compared to 3 out of 10 of the
overweight and 6 out of 10 of the women with normal BMI (Table 2).
Fig. 1 illustrates the prevalence of the healthy metabolic phenotype
according to women's waist circumference and BMI evolution from
prepregnancy to 4 years later, by women's BMI. Within each BMI stra-
tum, a waist circumference below 88 cm was associated with a signiﬁ-
cantly higher prevalence of a healthy metabolic proﬁle (for example,
among the obese: 28.2% vs. 10.3%, p = 0.001). However, BMI evolution
from prepregnancy to 4 years later did not inﬂuence the prevalence of aTable 1
Participants' characteristics 4 years after delivery of a liveborn, according to BMI (Portugal, 200
Normal
n (%)a
Overall 867 (46.9)
Age
Mean (SD) 34.4 (5.2)
Education (years)
≤9 323 (37.3)
10–12 256 (29.6)
N12 286 (33.1)
Working condition
Employed 700 (81.2)
Unemployed 119 (13.8)
Housewife 26 (3.0)
Others 19 (2.2)
Marital status
Married/living together 614 (87.5)
Others 88 (12.5)
Family history of CVD/cardiometabolic risk factorsb
No 181 (20.9)
Yes 686 (79.1)
Number of pregnancies (including index)
1 423 (48.8)
2 328 (37.8)
≥3 116 (13.4)
Type of delivery (índex pregnancy)
Vaginal 566 (65.8)
Caesarean 294 (34.2)
Breastfeeding (index child)
Never 33 (3.8)
≤26 weeks 515 (59.7)
N26 weeks 314 (36.4)
Use of hormonal contraceptives
Never 45 (5.2)
Former 318 (36.8)
Current 502 (58.0)
Smoking status
Never 475 (54.8)
Former 251 (29.0)
Current 141 (16.2)
Regular physical exercise
No 681 (78.6)
Yes 186 (21.4)
Waist circumference (cm)
≤88 850 (98.0)
N88 17 (2.0)
BMI evolution (Prepregnancy — 4 years later)
Same prepregnancy BMI 775 (89.4)
Recent increase in BMI 29 (3.5)
Recent decrease in BMI 31 (3.7)
BMI, body mass index; CVD, cardiovascular diseases; NA, not applicable; SD, standard deviatio
Note: In each variable, the total may not add up to 1847 due to missing data.
a Except for age, summarized as mean and standard deviation.
b Family history of CVD or cardiometabolic risk factors was considered when women report
stroke or myocardial infarction.metabolically healthy proﬁle, independently of the BMI category
(Fig. 1).
In the crude analysis and compared to women with normal BMI,
being unemployed or a housewife was associated with a higher likeli-
hood of being obese with a not healthymetabolic proﬁle (unemployed:
OR = 1.69; 95% CI: 1.21–2.36; housewife: OR = 2.22; 95% CI: 1.21–
4.09). Having a family history of CVD/cardiometabolic risk factors was
associated with a higher probability of having excessive weight and a
non-healthy metabolic proﬁle, this association being stronger for
obese women (OR = 1.41 95% CI: 1.00–1.98). The number of previous
pregnancies increased the odds of having a higher BMI independently
of themetabolic proﬁle, butwith a stronger associationwith healthy ex-
cessive weight. Breastfeeding was gradually and inversely associated
with BMI, with a stronger association for not healthy than healthy
excessive weight. Compared to women with normal BMI, women who9–2011).
Body mass index 4 years after delivery
Overweight Obese
n (%)a n (%)a p
612 (33.2) 368 (19.9)
35.2 (5.2) 35.3 (5.3) 0.002
318 (52.0) 214 (58.2)
177 (28.9) 94 (25.5)
117 (19.1) 60 (16.3) b0.001
461 (75.3) 266 (72.3)
120 (19.6) 70 (19.0)
19 (3.1) 22 (6.0)
12 (2.0) 10 (2.7) 0.004
453 (89.2) 255 (87.9)
55 (10.8) 35 (12.1) 0.658
113 (18.5) 60 (16.3)
499 (81.5) 308 (83.7) 0.151
252 (41.2) 144 (39.2)
240 (39.2) 128 (34.9)
120 (19.6) 96 (25.8) b0.001
386 (63.9) 207 (56.7)
218 (36.1) 158 (43.3) 0.010
34 (5.6) 33 (9.0)
333 (54.8) 216 (58.7)
241 (39.6) 119 (32.3) 0.002
24 (3.9) 26 (7.1)
225 (36.9) 181 (49.3)
361 (59.2) 162 (43.6) b0.001
364 (59.5) 217 (59.0)
145 (23.7) 91 (24.7)
103 (16.8) 60 (16.3) 0.203
485 (79.4) 321 (87.2)
126 (20.6) 47 (12.8) 0.001
380 (62.1) 39 (10.6)
232 (37.9) 329 (89.4) b0.001
272 (44.4) 153 (41.6)
298 (50.6) 195 (56.0)
19 (3.2) NA b0.001
n.
ed having at least one parent or sibling affected by diabetes, hypertension, dyslipidemia,
Table 2
Metabolic Characteristics of women 4 years after delivery of a liveborn, according to BMI (Portugal, 2009–2011).
Body mass index 4 years after delivery
Normal Overweight Obese p
Systolic blood pressure (mm Hg), mean (SD) 103.7 (10.8) 108.7 (12.5) 111.0 (12.7) b0.001
Diastolic blood pressure (mm Hg), mean (SD) 70.4 (8.6) 74.7 (9.8) 77.8 (10.2) b0.001
Fasting glucose (mg/dl), mean (SD) 80.2 (12.1) 82.3 (7.9) 85.7 (10.7) b0.001
C-reactive protein (mg/l), median (IQR) 1.1 (0.5–2.6) 1.9 (0.9–4.0) 3.2 (1.7–5.4) b0.001
Total cholesterol (mg/dl), mean (SD) 188.6 (33.5) 196.0 (38.8) 200.0 (34.6) b0.001
LDL cholesterol (mg/dl), mean (SD) 111.8 (27.6) 119.0 (32.3) 124.6 (30.2) b0.001
HDL cholesterol (mmol/l), mean (SD) 60.4 (13.2) 57.5 (11.8) 53.5 (11.9) b0.001
Triglycerides (mmol/l), median (IQR) 74 (56–99) 86 (63–117) 95 (75–132) b0.001
HOMA-IRa, median (IQR) 1.1 (0.8–1.5) 1.6 (1.2–2.2) 2.2 (1.7–3.1) b0.001
Metabolically healthyb, n (%) 525 (60.6) 200 (32.7) 45 (12.2) b0.001
BMI, bodymass index; IQR, interquartile range; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; SD, standard
deviation.
a Computed as fasting plasma glucose (mmol/l) ∗ fasting serum insulin (μU/ml) / 22.5.
b Deﬁned as the absence of hypertension, diabetes, dyslipidemia, a level of C-reactive protein below 3 mg/l and being below the second tertile of HOMA.
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more chances of being overweight and having a not healthy metabolic
proﬁle (OR = 2.32 95% CI: 1.18–4.56) but a different trend was found
considering obese women with the same phenotype (OR = 0.59 95%
CI: 0.35–1.01). Doing any kind of regular physical exercise was associat-
edwith a lower likelihood of being obese and having a not healthymet-
abolic phenotype (OR = 0.50 95% CI: 0.35–0.73) (Table 3).
Table 4 presents the results of the multivariate analysis. Having
a family history of CVD/cardiometabolic risk factors was associated
with a higher probability of having excessive weight and a not healthy
metabolic proﬁle, this association being stronger for obese women
(OR = 1.39 95% CI: 0.98–1.98), whereas no association was observed
with a healthy excessive weight. A graded inverse association was
found between breastfeeding the Generation XXI child for more than
26 weeks and BMI at 4 years with a not healthy metabolic proﬁle
(obesity, not healthy — OR = 0.39 95% CI: 0.23–0.68), and the effect
was null on healthy excessive weight. The pattern described in the
crude analysis for hormonal contraceptive use was independent of
confounders. Finally, doing any kind of physical exercise remainedFig. 1. Prevalence of healthymetabolic proﬁle by bodymass index and fat characteristics inmot
index evolution). BMI, bodymass index;WC,waist circumference. ⁎Computed as the difference
BMI were scarce and were not considered. †p b 0.05 for the comparison between WC ≤ 88 andassociated with a lower likelihood of being obese and having a not
healthy metabolic proﬁle (OR = 0.48 95% CI: 0.33–0.70).
Discussion
Our results support the existence of a healthy metabolic proﬁle in
women 4 years after delivery, with 3 out of 10 overweight women
and 1 out of 10 obese women presenting this phenotype. Abdominal
obesity strongly inﬂuences the prevalence of a healthy metabolic pro-
ﬁle, whereas BMI evolution from prepregnancy to 4 years after birth
does not. Genetic, reproductive and lifestyles features are associated
with this healthy phenotype and can help to better characterize this
metabolic proﬁle.
The prevalence of the healthy obesity phenotype varies according to
obesity markers and criteria used to deﬁne metabolic abnormalities,
impairing the comparability among studies (Velho et al., 2010). When
healthy obesity is deﬁned as having none or one of the six more com-
mon cardiometabolic abnormalities (elevated blood pressure, elevated
triglyceride level, decreased HDL level, elevated glucose level, insulinhers of a Portuguese birth cohort, 2009–2011 (Left panel: location; Right panel: bodymass
between BMI 4 years after delivery and BMI before pregnancy.Womenwith a decrease in
WC N 88.
Table 3
Crude odds ratio for the association between demographic, genetic, reproductive and behavioral characteristics and metabolic proﬁle, according to body mass index, in mothers of a
Portuguese birth cohort, 2009-2011.
Normal BMI Overweight Obese
Healthy Not healthy Healthy Not healthy
Overall, n (%) 867 (46.9) 200 (10.8) 412 (22.3) 45 (2.4) 323 (17.5)
Crude OR (95% CI)
Age 1 1.04 (1.01–1.07) 1.03 (1.00–1.05) 1.09 (1.02–1.15) 1.03 (1.00–1.05)
Education (years)
≤9 1 1 1 1 1
10–12 1 0.90 (0.63–1.30) 0.62 (0.47–0.82) 0.50 (0.24–1.01) 0.56 (0.41–0.76)
N12 1 0.63 (0.43–0.92) 0.33 (0.24–0.46) 0.24 (0.10–0.60) 0.33 (0.23–0.46)
Work condition
Employed 1 1 1 1 1
Unemployed 1 1.51 (1.01–2.26) 1.54 (1.12–2.11) 0.65 (0.23–1.87) 1.69 (1.21–2.36)
Housewife 1 0.88 (0.33–2.34) 1.22 (0.63–2.37) 2.24 (0.65–7.76) 2.22 (1.21–4.09)
Others 1 0.97 (0.32–2.89) 0.95 (0.41–2.20) 2.05 (0.46–9.13) 1.28 (0.55–2.97)
Marital status
Married/living together 1 1 1 1 1
Others 1 0.78 (0.45–1.35) 0.88 (0.59–1.32) 1.16 (0.44–3.08) 0.93 (0.60–1.45)
Family history of CVD/cardiometabolic risk factors
No 1 1 1 1 1
Yes 1 0.99 (0.68–1.45) 1.27 (0.94–1.72) 1.06 (0.50–2.23) 1.41 (1.00–1.98)
Number of pregnancies
1 1 1 1 1 1
2 1 1.37 (0.97–1.93) 1.16 (0.90–1.51) 1.75 (0.86–3.54) 1.08 (0.81–1.45)
≥3 1 1.94 (1.26–2.99) 1.65 (1.18–2.30) 3.12 (1.41–6.94) 2.33 (1.65–3.28)
Type of delivery
Vaginal 1 1 1 1 1
Cesarean 1 0.98 (0.70–1.35) 1.14 (0.89–1.46) 1.76 (0.96–3.23) 1.43 (1.10–1.86)
Breastfeeding
Never 1 1 1 1 1
≤26 weeks 1 0.75 (0.35–1.62) 0.58 (0.34–1.00) 0.51 (0.15–1.79) 0.41 (0.24–0.69)
N26 weeks 1 0.97 (0.45–2.11) 0.66 (0.38–1.16) 0.63 (0.18–2.25) 0.35 (0.20–0.61)
Use of hormonal contraceptives
Never 1 1 1 1 1
Former 1 1.21 (0.63-2.32) 1.47 (0.73-2.93) 1.60 (0.47-5.44) 0.90 (0.53-1.55)
Current 1 0.52 (0.27–1.02) 2.32 (1.18–4.56) 0.24 (0.06–0.93) 0.59 (0.35–1.01)
Smoking status
Never 1 1 1 1 1
Current 1 1.06 (0.74–1.51) 0.63 (0.47–0.84) 0.69 (0.34–1.41) 0.81 (0.60–1.10)
Former 1 1.23 (0.81–1.87) 0.84 (0.60–1.17) 0.45 (0.16–1.30) 1.01 (0.71–1.44)
Practice of physical exercise
Sedentary 1 1 1 1 1
Does any kind of exercise 1 0.97 (0.67–1.42) 0.94 (0.70–1.26) 0.79 (0.36–1.73) 0.50 (0.35–0.73)
95% CI, 95% conﬁdence interval; BMI, body mass index; CVD, cardiovascular diseases; OR, odds ratio; WC, waist circumference.
Table 4
Multivariate-adjusted odds ratio for the association between age, family history of cardiovascular diseases/cardiometabolic risk factors, breastfeeding, use of hormonal contraceptives and
physical exercise with metabolic proﬁle, according to body mass index, in mothers of a Portuguese birth cohort, 2009–2011.
Normal BMI Overweight Obese
Healthy Not healthy Healthy Not healthy
Adjusted OR (95% CI)a
Age 1 1.02 (0.98–1.05) 1.04 (1.01–1.06) 1.04 (0.98–1.11) 1.01 (0.99–1.04)
Family history of CVD/cardiometabolic risk factors
No 1 1 1 1 1
Yes 1 0.93 (0.63–1.38) 1.21 (0.89–1.66) 0.87 (0.40–1.88) 1.39 (0.98–1.98)
Breastfeeding
Never 1 1 1 1 1
≤26 weeks 1 0.84 (0.39–1.82) 0.58 (0.33–1.00) 0.65 (0.18–2.33) 0.44 (0.26–0.74)
N26 weeks 1 1.10 (0.50–2.40) 0.64 (0.37–1.12) 0.85 (0.23–3.08) 0.39 (0.23–0.68)
Use of hormonal contraceptives
Never 1 1 1 1 1
Former 1 1.22 (0.63–2.36) 1.35 (0.67–2.73) 1.66 (0.48–5.69) 0.88 (0.50–1.52)
Current 1 0.55 (0.23–1.07) 2.55 (1.29–5.04) 0.27 (0.07–1.09) 0.60 (0.35–1.04)
Practice of physical exercise
Sedentary 1 1 1 1 1
Does any kind of exercise 1 0.93 (0.63–1.36) 0.92 (0.68–1.23) 0.71 (0.32–1.56) 0.48 (0.33–0.70)
95% CI, 95% conﬁdence interval; BMI, body mass index; OR, odds ratio; WC waist circumference.
Note: performed only with women with information for all the variables considered (n = 1825).
a Each factor in the table is adjusted for every other factor in the table.
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54 A. Henriques et al. / Preventive Medicine 75 (2015) 49–55resistance and systemic inﬂammation), data suggest that 35.4% of
North American obese women possess a healthy phenotype but it
decreases drastically when we restrict the criteria to not having any of
the cardiometabolic risk factors with only 16.6% maintaining the
same phenotype (Wildman et al., 2008). In Europe, a lower prevalence
was found in cohort studies, ranging from 7% in Finland to 28% in the
United Kingdom, using the same criteria in all countries (Van Vliet-
Ostaptchouk et al., 2014). The most common deﬁnitions of healthy
obesity were compared in a Swiss population-based sample and less
than 5% of all obese subjects were considered metabolically healthy
by all deﬁnitions used and irrespective of the anthropometric markers
used (Velho et al., 2010). The prevalence found in our work among
obese women was similar to only one study mentioned above
(Karelis, 2008). Nevertheless, in our study we considered a particular
population:womenwho recently experienced pregnancy, which brings
speciﬁc body fat characteristics that needed to be studied in order to de-
termine their impact on women's metabolic proﬁle.
Concerning the deﬁnition of our outcome, the majority of published
work uses similar parameters (Manu et al., 2012; Stefan et al., 2008; Van
Vliet-Ostaptchouk et al., 2014; Velho et al., 2010) and for diabetes, dys-
lipidemia, C-reactive protein and blood pressure the cut-off values are
well deﬁned. For insulin, there is no cut-off clearly separating insulin
sensitive and resistant subgroups (Bluher, 2010). It is common to deﬁne
insulin resistance using the three upper quartiles (Karelis et al., 2008) of
HOMA-IR or above the 90th percentile (Wildman et al., 2008); however,
mean values of HOMA-IR in our sample were considerably lower.
Therefore, we used another threshold that was also previously used in
samples that have HOMA-IR values closer to ours (Manu et al., 2012).
Additionally, the cut-off of 1.803 that we used is only slightly lower
than thresholds for insulin resistance in recent population studies
which ranged from 2.1 to 3.8 (Manu et al., 2012).
Since central fat deposition is strongly associated with CVD risk
independently of BMI (Demerath et al., 2008), it was hypothesized
that waist circumference could play a role in the distinction between
healthy and not healthy proﬁle. In this sample of Portuguese women
whoachieved a successful pregnancy, abdominal obesitywas associated
with a lower probability of having a healthy metabolic proﬁle in every
BMI stratum. Given the important role of visceral adipose tissue in the
genesis of both insulin resistance and inﬂammation (Diamant et al.,
2005), it is not surprising that a relatively lower amount of abdominal
adiposity could explain a more favorable metabolic proﬁle even in
women who recently gained weight.
It remains unclear whether this favorable proﬁle represents a per-
manent characteristic or is just a step in the natural history of obesity.
Longitudinal data concerning this subject are scarce. A recent study
showed that among overweight/obese metabolically healthy subjects
at baseline, 57% developed one or more cardiometabolic risk factor
3 years later (Bobbioni-Harsch et al., 2012). Moreover, a recent meta-
analysis highlights that the incidence of cardiometabolic distur-
bances is not linear over time among healthy obese people and the du-
ration of follow-up can be a critical element in this evaluation, since
differences between healthy and not-healthy subjects in the incidence
of events were evident only after 10 years (Kramer et al., 2013).
Concerning our study population, longitudinal studies are needed and
it is expected that the next follow-ups of the Generation XXI cohort
will provide more information to address all the uncertainty regarding
the duration of this healthy phenotype.
To date, little is known about the factors that delay the onset of or
protect individuals with excessive weight from developing metabolic
disturbances. Physical activity inﬂuences the prevalence of a healthy
cardiometabolic proﬁle (Velho et al., 2010; Wildman, 2009; Yoo et al.,
2013).Moderate regular physical activity is associatedwith higher insu-
lin sensitivity, an improved lipid proﬁle, and a decrease in components
of metabolic syndrome (Caro et al., 2013) and this fact can explain the
lower probability of being obese and metabolically not healthy among
women who practice any kind of physical exercise.Having a family history of CVD or cardiometabolic risk factors in-
creases the chances of having a non-healthy metabolic proﬁle among
obese women which suggests that this phenotype can also be the ex-
pression of a genetic trait. Knowing that fat deposition on the visceral
area is inﬂuenced by genes (Fox et al., 2007), genetic background possi-
bly inﬂuences healthy metabolic proﬁle, however up to now no evi-
dence supports this hypothesis.
No study was found that tried to ascertain the impact of the use of
hormonal contraceptives and the duration of breastfeeding on healthy
metabolic proﬁle. It is already established that duration of breastfeeding
is inversely associated withmother's obesity (Turcksin et al., 2014) and
this study adds that, even among obese women, the longer one
breastfeeds the lower the probability of having an adverse metabolic
proﬁle, conﬁrming the beneﬁcial effect of breastfeeding also at a meta-
bolic level. Regarding the use of hormonal contraceptives, discrepant re-
sults were observed in overweight and obese women and we believe
that this difference can be partly explained by reverse causality: contra-
ception is often feared in women with chronic medical problems like
obesity and these women might not be using hormonal contraceptives
at the time of the evaluation in consequence of their obesity.
Our study has several strengths including a large sample size of
women who recently were mothers and the assessment of this healthy
phenotype in this particular population which was unexplored so far.
Also, using objective measures of height, weight and waist circumfer-
ence allowed us to have a more accurate estimation of overweight and
obesity. However, some limitations can also be identiﬁed. BMI was
used to classify overweight and obesewomen anddoes not discriminate
between lean and fat bodymass.Moreover, the cross sectional studyde-
sign limited our ability to make an inference about causal relationships
between exposure and outcome variables.
Conclusions
These results support the existence of a healthy metabolic pheno-
type in overweight and obese women after motherhood, inﬂuenced
by anthropometrics, genetic and lifestyles characteristics. Since preg-
nancy promotes abdominal obesity, young adult womenwith excessive
weight might need a close surveillance of their cardiometabolic param-
eters as well as prevention for further weight gain.
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